Full Breakdown
CoreWeave's $9 Billion Bid for Core Scientific Faces Shareholder Opposition
10/22/2025, 12:34:41 PM
Overview of the Proposed Acquisition
CoreWeave Inc., an AI cloud provider backed by Nvidia, proposed an all-stock acquisition of Core Scientific Inc., a data center operator, valued at approximately $9 billion in July 2025. The deal is set for a shareholder vote on October 30, 2025. However, significant opposition has emerged from key stakeholders, including proxy advisory firms and major shareholders.
Shareholder Sentiment and Advisory Recommendations
Institutional Shareholder Services (ISS) and Glass Lewis, two prominent proxy advisory firms, have recommended that Core Scientific shareholders reject the acquisition. ISS criticized the deal structure, stating that it leaves Core Scientific investors vulnerable to fluctuations in CoreWeave's share price, which has declined since the announcement. They argue that Core Scientific has demonstrated considerable success as an independent entity and may have greater upside potential if it remains standalone. Major shareholder Two Seas Capital, holding a 6.2% stake in Core Scientific, has also voiced opposition, citing concerns over the valuation and the sale process.
CoreWeave's Position and Market Dynamics
Despite the pushback, CoreWeave's CEO Michael Intrator has reiterated that the company will not increase its bid, asserting that the proposed price accurately reflects the value of both firms. He expressed disappointment over the advisory firms' recommendations but emphasized that the acquisition is a "nice to have" rather than a necessity for CoreWeave. The company has been expanding rapidly in the AI infrastructure sector, securing significant contracts with major clients like OpenAI and Meta Platforms, which have contributed to a substantial rise in its stock price—over 200% since its IPO in March 2025.
Financial Implications and Market Context
The proposed acquisition comes amid a broader surge in demand for AI infrastructure, with companies like CoreWeave and its competitor Nebius Group experiencing remarkable sales growth. CoreWeave's revenue for the second quarter of 2025 reached $1.2 billion, a significant increase from the previous year. However, this growth has been accompanied by a heavy debt load, with CoreWeave's net debt exceeding $10 billion as it invests heavily in expanding its data center capabilities.
Criticism and Concerns
Critics of the acquisition argue that the current market conditions and the rapid rise in Core Scientific's stock price indicate that shareholders may be better off rejecting the deal. The value of Core Scientific's shares has risen since the announcement of the acquisition, suggesting that investors believe the company is worth more than CoreWeave's offer. The potential for a bidding war or alternative offers remains uncertain, as CoreWeave's position appears firm.
What's Next?
As the October 30 vote approaches, the outcome remains uncertain. If shareholders reject the deal, CoreWeave may need to explore other avenues for growth, while Core Scientific will have to navigate its future independently. The dynamics of the AI infrastructure market continue to evolve, and both companies will need to adapt to the changing landscape.
Verbatim Quotes
- “We think that the bid that we put out there for [Core Scientific] is a fair representation of the relative value of the two companies as an all stock deal,” — Michael Intrator, CEO of CoreWeave
- “The market believes the company's value is greater than the offer,” — Institutional Shareholder Services
This situation highlights the complexities of mergers and acquisitions in the rapidly evolving AI sector, where valuations can fluctuate dramatically based on market sentiment and performance.
